Global Branded Generics Market
Branded Generics Market Size And Forecast
According to Verified Market Research, Global Branded Generics Market was valued at USD 221.18 Billion in 2018 and is projected to reach USD 392.15 Billion by 2026, growing at a CAGR of 7.38% from 2019 to 2026.
Global Branded Generics Market Outlook
The key factor such as the growing number of patents expired and expiring for branded drugs is majorly expected to boost the growth of the global branded generic market. Moreover, the rising incidents and population suffering from chronic diseases and disorders are further expected to propel the growth of the market. Furthermore, entry of new players, simple marketing authorization procedures, changing medicine practices, greater profit margin are some other factors fueling the market growth. However, huge competition from branded drugs and commodity generic products and lack of penetration associated with the number of generic drugs worldwide are the key factors that might hamper the market growth.
Global Branded Generics Market Competitive Landscape
The Global Branded Generics Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as ZydusCadila, Teva Pharmaceutical Industries Ltd, Dr. Reddys Laboratories Ltd., Mylan N.V., Hospira Inc., Valeant, Apotex Inc., GlaxoSmithKline Pharmaceuticals Limited, Sandoz, Lupin Pharmaceuticals, Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.